Tsinghua University School of Medicine, Beijing, 100084, China.
Department of Pulmonary and Critical Care Medicine, Center for Respiratory Medicine, China-Japan Friendship Hospital, Beijing, 100029, China.
Front Med. 2020 Apr;14(2):225-228. doi: 10.1007/s11684-020-0753-1. Epub 2020 Mar 20.
The 2019 novel coronavirus (2019-nCoV) is an emerging pathogen and is threatening the global health. Strikingly, more than 28 000 cases and 550 deaths have been reported within two months from disease emergence. Armed with experience from previous epidemics in the last two decades, clinicians, scientists, officials, and citizens in China are all contributing to the prevention of further 2019-nCoV transmission. Efficient preliminary work has enabled us to understand the basic characteristics of 2019-nCoV, but there are still many unanswered questions. It is too early now to judge our performance in this outbreak. Continuous and strengthened efforts should be made not only during the epidemic, but also afterwards in order to prepare for any incoming challenges.
2019 新型冠状病毒(2019-nCoV)是一种新兴病原体,正在威胁全球健康。令人震惊的是,在疾病出现后的两个月内,已报告超过 28000 例病例和 550 例死亡。中国的临床医生、科学家、官员和公民凭借过去二十年来的历次疫情经验,都在为预防 2019-nCoV 的进一步传播做出贡献。有效的初步工作使我们能够了解 2019-nCoV 的基本特征,但仍有许多悬而未决的问题。现在判断我们在此次疫情中的表现还为时过早。不仅在疫情期间,而且在疫情过后,都应持续加强努力,为应对任何新出现的挑战做好准备。